A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University and institutions across the U.S.

A newly identified loss of cellular identity may enable colorectal cancer cells to enter a highly flexible state that ...

Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells ...

Wes Hensel had complained to his doctors about occasional rectal bleeding for 4 years. But his gastroenterologist assured him ...

Loss of GATA6-a transcription factor that controls which genes are turned on or off-can reprogram colorectal cancer cells ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD ...

Colorectal cancer (CRC) is the third most common and the second most lethal human cancer, with a worldwide incidence of nearly 2 million cases and close to 1 million deaths annually 1. Most CRCs arise ...

Colorectal cancer (CRC) arises through a combination of inherited and acquired genetic alterations that disrupt key pathways of DNA repair, cell growth and immune surveillance. Germline variants in ...

A research team at the Korea Institute of Materials Science (KIMS) has developed a plasmonics-based liquid biopsy platform ...